Alnylam Pharmaceuticals has published data on the use of combinations of novel lipid materials to systemically deliver RNAi therapeutics.
The work was conducted by Alnylam researchers in collaboration with scientists at the Massachusetts Institute of Technology (GSN 5/10/2007), and appeared in Molecular Therapy.
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Parabon NanoLabs is partnering with law enforcement to use genetic genealogy approaches to solve cold cases, Buzzfeed News reports.
A Columbia University-led team used emergency contact information from medical records to create family trees and estimate disease heritability.
In Science this week: ancient Southeast Asian genomes provide insight on human migration, and more.
NPR says a new report recommends that former research chimpanzees should be moved to retirement sanctuaries unless that move would shorten their lives.
This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.